Clensta International, an IIT Delhi partnered healthcare start-up revolutionizing the personal hygiene space, recently announced extension of their marketing and distribution partnership with Cipla, one of the leading global pharmaceutical company in India for its waterless technology products. This deal will redefine the hygiene and cleanliness for patients in hospital setups, primarily focusing on ICUs […]
Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the United States Food and Drug Administration (US FDA). Cipla’s Difluprednate Ophthalmic Emulsion 0.05% is AB-rated generic therapeutic equivalent version of Novartis […]
Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as “Cipla” today announced that its subsidiary, Cipla Gulf FZ LCC (“Cipla Gulf’) is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand. As part of this strategic alliance, Cipla Gulf will be responsible for commercialization of patented biosimilars […]
CIPLA Limited launched its third chapter of the #BerokZindagi campaign with a new digital film aimed to dispel myths and fears regarding asthma and encourage asthmatics to lead a life without limitations. The film highlights the core message, “Asthma ke liye, inhalers hain sahi” (inhalers are right for asthma3,4,5). India has 37.9 million cases of […]
